• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘露糖6-磷酸通过取代抑制性内源性配体来增加其不依赖阳离子的受体对胰岛素样生长因子II的亲和力。

Mannose 6-phosphate increases the affinity of its cation-independent receptor for insulin-like growth factor II by displacing inhibitory endogenous ligands.

作者信息

Polychronakos C, Guyda H J, Posner B I

机构信息

Department of Pediatrics, McGill University, Montreal, Quebec, Canada.

出版信息

Biochem Biophys Res Commun. 1988 Dec 15;157(2):632-8. doi: 10.1016/s0006-291x(88)80297-3.

DOI:10.1016/s0006-291x(88)80297-3
PMID:2974283
Abstract

The insulin-like growth factor II (IGF-II) and glycoprotein lysosomal enzymes containing mannose 6-phosphate (M6P) bind with high affinity to two separate sites on the same receptor molecule (Morgan et al. Nature 329:301). The addition of free M6P significantly increases the affinity of some preparations of the M6P/IGF-II receptor (M6P/IGF-II-R) for IGF-II. We conducted this study to test the hypothesis that this effect is the result of displacement of M6P-related ligands that inhibit IGF-II binding. First we found that although M6P caused a 66% increase in the binding of IGF-II to microsomes prepared from IM9 cells, it had no effect, under identical conditions, on binding to receptor on the surface of intact cells. Secondly, extensive washing of rat liver microsomes in the presence of 3 mM M6P, followed by removal of the M6P by further washing, abolished the effect by raising binding to levels seen in the presence of M6P. M6P, then, had no additional effect. Finally, when IGF-II-affinity purified receptor was repurified by ultracentrifugation on a sucrose gradient, binding to the pure receptor peak was not affected by M6P. We conclude that there is no intrinsic positive cooperativity between free M6P and the IGF-II-binding site of the M6P/IGF-II-R. The reported M6P-induced increase in IGF-II binding appears to be due to the displacement of contaminating inhibitory endogenous ligands.

摘要

胰岛素样生长因子II(IGF-II)和含有甘露糖6-磷酸(M6P)的糖蛋白溶酶体酶以高亲和力结合到同一受体分子上的两个不同位点(摩根等人,《自然》329:301)。游离M6P的添加显著增加了某些M6P/IGF-II受体(M6P/IGF-II-R)制剂对IGF-II的亲和力。我们进行这项研究以检验以下假设:这种效应是抑制IGF-II结合的M6P相关配体被置换的结果。首先,我们发现尽管M6P使IGF-II与从IM9细胞制备的微粒体的结合增加了66%,但在相同条件下,它对完整细胞表面受体的结合没有影响。其次,在3 mM M6P存在下对大鼠肝脏微粒体进行广泛洗涤,然后通过进一步洗涤去除M6P,通过将结合提高到在M6P存在下所见的水平消除了这种效应。那么,M6P没有额外的作用。最后,当通过在蔗糖梯度上超速离心对IGF-II亲和纯化的受体进行再纯化时,M6P对与纯受体峰的结合没有影响。我们得出结论,游离M6P与M6P/IGF-II-R的IGF-II结合位点之间不存在内在的正协同作用。所报道的M6P诱导的IGF-II结合增加似乎是由于污染性抑制内源性配体的置换。

相似文献

1
Mannose 6-phosphate increases the affinity of its cation-independent receptor for insulin-like growth factor II by displacing inhibitory endogenous ligands.甘露糖6-磷酸通过取代抑制性内源性配体来增加其不依赖阳离子的受体对胰岛素样生长因子II的亲和力。
Biochem Biophys Res Commun. 1988 Dec 15;157(2):632-8. doi: 10.1016/s0006-291x(88)80297-3.
2
Endocytosis of receptor-bound insulin-like growth factor II is enhanced by mannose-6-phosphate in IM9 cells.在IM9细胞中,6-磷酸甘露糖可增强受体结合型胰岛素样生长因子II的内吞作用。
Endocrinology. 1988 Oct;123(4):2146-8. doi: 10.1210/endo-123-4-2146.
3
Endocytosis of receptor-bound insulin-like growth factor II is enhanced by mannose-6-phosphate in IM9 cells.在IM9细胞中,甘露糖-6-磷酸可增强受体结合型胰岛素样生长因子II的内吞作用。
Endocrinology. 1988 Dec;123(6):2943-5. doi: 10.1210/endo-123-6-2943.
4
Effects of mannose-6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II.甘露糖-6-磷酸对胰岛素样生长因子-II受体介导的内吞作用的影响。
Endocrinology. 1990 Oct;127(4):1861-6. doi: 10.1210/endo-127-4-1861.
5
Interactions of the receptor for insulin-like growth factor II with mannose-6-phosphate and antibodies to the mannose-6-phosphate receptor.胰岛素样生长因子II受体与6-磷酸甘露糖及6-磷酸甘露糖受体抗体的相互作用
Biochem Biophys Res Commun. 1987 Dec 16;149(2):600-6. doi: 10.1016/0006-291x(87)90410-4.
6
Mannose 6-phosphate/insulin like growth factor II receptor: the two types of ligands bind simultaneously to one receptor at different sites.甘露糖6-磷酸/胰岛素样生长因子II受体:两种配体在不同位点同时结合到一个受体上。
Biochem Biophys Res Commun. 1988 May 16;152(3):1248-54. doi: 10.1016/s0006-291x(88)80419-4.
7
Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.通过靶向甘露糖6-磷酸/胰岛素样生长因子II受体的基于多齿五甘露糖基6-磷酸的配体抑制胰岛素样生长因子II(IGF-II)依赖性细胞生长。
Oncotarget. 2016 Sep 20;7(38):62386-62410. doi: 10.18632/oncotarget.11493.
8
Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.生化证据表明II型胰岛素样生长因子受体与不依赖阳离子的甘露糖6-磷酸受体相同。
J Biol Chem. 1988 Jul 5;263(19):9339-44.
9
Activation of osteoblast insulin-like growth factor-II/cation-independent mannose-6-phosphate receptors by specific phosphorylated sugars and antibodies induce insulin-like growth factor-II effects.特定磷酸化糖类和抗体对成骨细胞胰岛素样生长因子-II/不依赖阳离子的甘露糖-6-磷酸受体的激活可诱导胰岛素样生长因子-II效应。
Endocr Res. 1991;17(3-4):357-66. doi: 10.1080/07435809109106813.
10
Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor.人血清和尿液中的甘露糖6-磷酸/胰岛素样生长因子II结合蛋白。它们与甘露糖6-磷酸/胰岛素样生长因子II受体的关系。
Biochem J. 1988 Jun 15;252(3):795-9. doi: 10.1042/bj2520795.

引用本文的文献

1
The insulin-like growth factor II/mannose-6-phosphate receptor : IGF-II/Man-6-P receptor.胰岛素样生长因子 II/甘露糖-6-磷酸受体:IGF-II/Man-6-P 受体。
Cytotechnology. 1989 Dec;2(4):287-305. doi: 10.1007/BF00364994.
2
Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.异源三聚体G蛋白与单跨膜结构域IGF-II/M6P受体:功能相互作用及其与细胞信号传导的相关性。
Mol Neurobiol. 2007 Jun;35(3):329-45. doi: 10.1007/s12035-007-0021-2.
3
Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate/IGF-II receptor.
组织蛋白酶D前体与胰岛素样生长因子-II在甘露糖-6-磷酸/胰岛素样生长因子-II受体上的相互作用。
Breast Cancer Res Treat. 1992;22(1):47-57. doi: 10.1007/BF01833333.